Ilan Ganot - Nov 10, 2025 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ David Tyronne Howton as attorney-in-fact for Ilan Ganot
Stock symbol
SLDB
Transactions as of
Nov 10, 2025
Transactions value $
-$13,505
Form type
4
Date filed
11/13/2025, 04:05 PM
Previous filing
Aug 18, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ganot Ilan Director C/O SOLID BIOSCIENCES INC., 500 RUTHERFORD AVENUE, THIRD FLOOR, CHARLESTOWN /s/ David Tyronne Howton as attorney-in-fact for Ilan Ganot 2025-11-13 0001727460

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDB Common Stock Sale -$13.5K -3.28K -3.32% $4.12 95.4K Nov 10, 2025 Direct F1, F2
holding SLDB Common Stock 14.8K Nov 10, 2025 Wife
holding SLDB Common Stock 19.4K Nov 10, 2025 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.11 to $4.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form.
F2 Represents 91,370 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
F3 Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.